The challenge of managing multiple cardiovascular risk factors

American Journal of Hypertension

Volumn 10, Issue 7 SUPPL. 1, 1997, Pages 167S-169S

  Kaplan, Norman M ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Drug side effects; Risk factors; Risk management; Treatment

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

BLOOD PRESSURE REGULATION; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTENSION; LIFESTYLE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING;

ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; HUMANS; RISK FACTORS;

EID: 0030785603     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00106-4     Document Type: Article

References (7)

1. Groppelli A, Giorgi DMA, Omboni S, et al: Persistent blood pressure increase induced by heavy smoking. J Hypertens 1992;10:495-499.
2. Lind L, Berne C, Lithell H: Prevalence of insulin resistance in essential hypertension. J Hypertens 1995;13: 1457-1462.
3. Jennings GL, Sudhir K: Initial therapy of primary hypertension. Med J Aust 1990;152:198-203.
4. Lithell HOL: Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 1991;14: 203-209.
5. Neaton JD, Grimm RH, Jr, Prineas RJ, et al: Treatment of mild hypertension study (TOMHS): final results. JAMA 1993;270:713-724.
6. Carlsen JE, Køber L, Torp-Pedersen C, Johansen P: Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. Br Med J 1990; 300:975-978.
7. Frishman WH, Bryzinski BS, Coulson LR, et al: A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med 1994;154:1461-1468.